Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02613585 · ClinicalTrials.gov registry record · NA
Tick-borne Illness and Clothing Study of Rhode Island
A NA study of Tick-borne Diseases and Tick Bites, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
- 1
- Study location
NCT02613585: Completed NA study of Tick-borne Diseases and Tick Bites, sponsored by University of North Carolina, Chapel Hill.
NCT02613585 is a NA study of Tick-borne Diseases and Tick Bites that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 135 participants, below the 6,697-participant average among 3 other Tick-borne Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02613585, a NA study of Tick-borne Diseases and Tick Bites, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
Lyme and other tick-borne diseases pose a significant health threat to outdoor workers. This study is a double-blind randomized controlled trial of outdoor workers in Rhode Island and the surrounding area that will address the following study aims: 1) Evaluate the effectiveness of LLPI clothing in preventing tick bites among outdoor workers in Lyme endemic areas; 2) Measure the urine levels of permethrin metabolites in study subjects; and 3) Measure the loss over time of knockdown activity against ticks and of permethrin in LLPI clothing.
Primary Outcome
Reported tick bites, defined as ticks attached to or embedded in the skin.
Conditions Studied
Interventions
- OTHER Permethrin Impregnated Clothing
Study Locations (1)
Rhode Island
- University of Rhode Island - Kingston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2016-02 |
| Est. Completion | 2020-12 |
| Phase | NA |
What the finished NCT02613585 record still lists
NCT02613585 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, below the 6,697-participant average among 3 other Tick-borne Diseases trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Tick-borne Diseases appearing as the primary indexed condition, and to 1 intervention - of which Permethrin Impregnated Clothing is the first listed.
NCT02613585 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT02613585 about?
NCT02613585 is a clinical study titled "Tick-borne Illness and Clothing Study of Rhode Island". Lyme and other tick-borne diseases pose a significant health threat to outdoor workers. This study is a double-blind randomized controlled trial of outdoor workers in Rhode Island and the surrounding area that will address the following study aims: 1) Evaluate the effectiveness of LLPI clothing in p...
What is the current status of trial NCT02613585?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2016-02. Estimated completion is 2020-12.
What conditions does trial NCT02613585 study?
This clinical trial studies the following conditions: Tick-borne Diseases, Tick Bites.
What interventions are being tested in trial NCT02613585?
The interventions under investigation include: Permethrin Impregnated Clothing (OTHER).
Who is sponsoring clinical trial NCT02613585?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02613585 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tick-borne Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia